Venture Challenge alumnus Predica is proud to announce its first product, the “HPV profiler”

Predica Diagnostics B.V. is active in the field of diagnostics, prognostics and prediction of treatment response in oncology. in 2018 Predica Diagnostic participated in the Venture Challenge spring edition. 

September 20th they announced their first product, the “HPV profiler”. This RUO assay is based on Predica’s targeted RNA sequencing platform and allows unique insights in HPV biology and HPV related diseases. Completion of this product is a great milestone, and will set the stage for our future development of diagnostic tools for Women's Health (Cervical Cancer, Vaginal Health and Endometriosis).

Click here for more information about Predica Diagnostics B.V.